Replay available

Fulgent Genetics, Inc. (FLGT) Q2 2026 Earnings Call

Fulgent Genetics, Inc. (NASDAQ: FLGT) Q2 2026 earnings conference call, held 2026-07-30. Replay captured from the company's public earnings webcast.

Thu, July 30, 2026 at 4:30 PMendedReplay
Fulgent Genetics, Inc. (FLGT) Q2 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Lauren Sloan

Investor Relations

Karan Patel

Analyst, Pepper Sandler

Ming Hsieh

Chief Executive Officer

Brandon Perthuis

Chief Commercial Officer

Paul Kim

Chief Financial Officer

Replay transcript excerpt

Greetings and welcome to the Folger Genetics second quarter 2026 conference call and webcast. At this time, all participants are in listen-only mode. A question and answer session will follow the formal presentation. You may be placed into question queue at any time by pressing star 1 on your telephone keypad. As a reminder, this conference is being recorded. If anyone should require operator assistance, please press star 0. It's now my pleasure to turn the call over to Lauren Sloan, Investor Relations. Lauren, please go ahead. Good afternoon and welcome to Fulgent's second quarter 2026 financial results conference call. On the call are Ming Hsieh, Chief Executive Officer, Paul Kim, Chief Financial Officer, and Brandon Perthuis, Chief Commercial Officer. The company's press release discussing the financial results is available on the investor relations section of the company's website, ir.fulgentgenetics.com. A replay of this call will be available shortly after the call concludes on the investor relations section of the company's website. Management's prepared remarks and answers to your questions on today's call will contain forward-looking statements. These forward-looking statements represent management's estimates based on current views, expectations, and assumptions, which may prove to be incorrect. As a result, matters discussed in any forward-looking statements are subject to risks, uncertainties, and changes in circumstances that may cause actual results to differ from those described in the forward-looking statement. The company assumes no obligation to update any of the forward-looking statements it may make today to reflect actual results or changes in expectations. Listeners should not rely on any forward-looking statements as predictions of the future a...

More from Fulgent Genetics, Inc.